ArchPoint Investors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-591
Closed -$34K 138
2018
Q2
$34K Hold
591
0.01% 125
2018
Q1
$24K Hold
591
0.01% 148
2017
Q4
$21K Hold
591
0.01% 139
2017
Q3
$20K Hold
591
0.01% 148
2017
Q2
$21K Hold
591
0.01% 149
2017
Q1
$14K Buy
+591
New +$12.3K 0.01% 139
2016
Q3
Sell
-591
Closed -$9K 139
2016
Q2
$9K Buy
591
+325
+122% +$3.79K 0.01% 135
2016
Q1
$3K Buy
+266
New +$3.78K ﹤0.01% 144

Other funds holding TDOC

ArchPoint Investors's TDOC Position: Q3 2018 in Review

ArchPoint Investors sold out of Teladoc Health (TDOC) in Q3 2018, closing a stake of 591 shares — an estimated $34K sold.

ArchPoint Investors first reported a position in TDOC in Q1 2016 and held it in 8 quarters. The position peaked at $34K in Q2 2018. 334 funds tracked by Wall St. Rank hold TDOC as of Q3 2018.

  • ArchPoint Investors reported no remaining Teladoc Health position as of Q3 2018 after selling out during the quarter.
  • ArchPoint Investors sold 591 Teladoc Health shares in Q3 2018, an estimated $34K.
  • ArchPoint Investors first reported a position in Teladoc Health in Q1 2016 and held it in 8 quarters.
  • ArchPoint Investors's Teladoc Health position peaked at $34K in Q2 2018.
  • 334 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2018.

Based on ArchPoint Investors's 13F filing for Q3 2018, filed 24 Oct 2018.